$ Value
$0
Shares
48,750
Price
$0
Filed
Feb 5
Insider
Name
Tingley Whittemore
Title
Chief Medical Officer
CIK
0001868494
Roles
Transaction Details
Transaction Date
2026-02-03
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
223,778
Footnotes
Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock. | The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested. | Includes 134,588 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. | Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.
Filing Info
Tingley Whittemore's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | TNYA | ▼ | $1K |
| 2026-02-17 | TNYA | ▼ | $1K |
| 2026-02-17 | TNYA | ▼ | $1K |
| 2026-02-03 | TNYA | A | $0 |
| 2026-02-03 | TNYA | A | $0 |
| 2025-11-17 | TNYA | ▼ | $4K |
| 2025-08-18 | TNYA | ▼ | $2K |
| 2025-08-18 | TNYA | ▼ | $2K |
| 2025-08-18 | TNYA | ▼ | $2K |
| 2025-05-16 | TNYA | ▼ | $1K |
Other Insiders at TNYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ali Faraz
Chief Executive Officer
|
— | $10K | 2026-02-17 |
| COLUMN GROUP III GP, LP | — | $5.9M | 2026-02-25 |
|
Tingley Whittemore
Chief Medical Officer
|
— | $3K | 2026-02-17 |
|
Higa Tomohiro
SVP, Finance
|
— | $2K | 2026-02-17 |